Anti-KLRC3 monoclonal antibody

Pre-made anti-KLRC3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KLRC3/KLRC3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1057-Ab-1/ GM-Tg-hg-IP1057-Ab-2Anti-Human KLRC3 monoclonal antibodyHuman
GM-Tg-rg-IP1057-Ab-1/ GM-Tg-rg-IP1057-Ab-2Anti-Rat KLRC3 monoclonal antibodyRat
GM-Tg-mg-IP1057-Ab-1/ GM-Tg-mg-IP1057-Ab-2Anti-Mouse KLRC3 monoclonal antibodyMouse
GM-Tg-cynog-IP1057-Ab-1/ GM-Tg-cynog-IP1057-Ab-2Anti-Cynomolgus/ Rhesus macaque KLRC3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1057-Ab-1/ GM-Tg-felg-IP1057-Ab-2Anti-Feline KLRC3 monoclonal antibodyFeline
GM-Tg-cang-IP1057-Ab-1/ GM-Tg-cang-IP1057-Ab-2Anti-Canine KLRC3 monoclonal antibodyCanine
GM-Tg-bovg-IP1057-Ab-1/ GM-Tg-bovg-IP1057-Ab-2Anti-Bovine KLRC3 monoclonal antibodyBovine
GM-Tg-equg-IP1057-Ab-1/ GM-Tg-equg-IP1057-Ab-2Anti-Equine KLRC3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1057-Ab-1/ GM-Tg-hg-IP1057-Ab-2; GM-Tg-rg-IP1057-Ab-1/ GM-Tg-rg-IP1057-Ab-2;
GM-Tg-mg-IP1057-Ab-1/ GM-Tg-mg-IP1057-Ab-2; GM-Tg-cynog-IP1057-Ab-1/ GM-Tg-cynog-IP1057-Ab-2;
GM-Tg-felg-IP1057-Ab-1/ GM-Tg-felg-IP1057-Ab-2; GM-Tg-cang-IP1057-Ab-1/ GM-Tg-cang-IP1057-Ab-2;
GM-Tg-bovg-IP1057-Ab-1/ GM-Tg-bovg-IP1057-Ab-2; GM-Tg-equg-IP1057-Ab-1/ GM-Tg-equg-IP1057-Ab-2
Products NameAnti-KLRC3 monoclonal antibody
Formatmab
Target NameKLRC3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KLRC3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1057-Ag-1Recombinant multi-species NKG2E/ KLRC3/ NKG2-E protein
    ORF Viral VectorpGMLPm000532mouse Klrc3 Lentivirus plasmid
    ORF Viral VectorpGMLPm003673mouse Klrc3 Lentivirus plasmid
    ORF Viral VectorvGMLPm000532mouse Klrc3 Lentivirus particle
    ORF Viral VectorvGMLPm003673mouse Klrc3 Lentivirus particle


    Target information

    Target IDGM-IP1057
    Target NameKLRC3
    Gene ID3823
    Gene Symbol and SynonymsKLRC3,NKG2-E,NKG2E
    Uniprot AccessionQ07444
    Uniprot Entry NameNKG2E_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000205810
    Target ClassificationN/A

    The target: KLRC3, gene name: KLRC3, also named as NKG2-E, NKG2E. Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. KLRC3 is a member of the NKG2 group which are expressed primarily in natural killer (NK) cells and encodes a family of transmembrane proteins characterized by a type II membrane orientation (extracellular C terminus) and the presence of a C-type lectin domain. The NKG2 gene family is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed on NK cells. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.